Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A First-in-human Phase I Single-agent Dose-escalation, Food Effect and Dose Expansion Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
The primary objective of this Phase 1, open-label, dose-escalation, and exploratory study is to evaluate the safety and tolerability profile (establish the max…
Central Nervous System NeoplasmsGlioblastomaGliosarcoma, Adult+20 more
Jazz PharmaceuticalsNCT04541082
Phase 2
A Phase 2, Single Arm, Multi-center, Open Label Trial Combining Optune With Concurrent Bevacizumab in the Setting of Recurrent or Progressive Meningioma
The purpose of this research study is to determine the effects bevacizumab (the study drug) combined with Optune (the study device) tumor treatment field thera…
Anaplastic (Malignant) MeningiomaAtypical MeningiomaGrade II Meningioma+3 more
Northwestern UniversityNCT02847559